Evidence map›Paper›PMID 27170700›Full record

ReviewJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2016

Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.

François De Guio, Eric Jouvent, Geert Jan Biessels, Sandra E Black, Carol Brayne, Christopher Chen, Charlotte Cordonnier, Frank-Eric De Leeuw, Martin Dichgans, Fergus Doubal and 31 more

Abstract readReview
In one paragraph

Review in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2020
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. segcsvdHuman brain mapping · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

François De GuioUniversity Paris Diderot, Sorbonne Paris Cité, UMRS 1161 INSERM, Paris, France DHU NeuroVasc, Sorbonne Paris Cité, Paris, France.
Eric JouventUniversity Paris Diderot, Sorbonne Paris Cité, UMRS 1161 INSERM, Paris, France DHU NeuroVasc, Sorbonne Paris Cité, Paris, France Department of Neurology, AP-HP, Lariboisière Hospital, Paris, France.
Geert Jan BiesselsDepartment of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Sandra E BlackDepartment of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Carol BrayneDepartment of Public Health and Primary Care, Cambridge University, Cambridge, UK.
Christopher ChenDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Charlotte CordonnierUniversity of Lille, CHU Lille, Inserm U1171, Lille, France.
Frank-Eric De LeeuwDonders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Department of Neurology, Nijmegen, The Netherlands.
Martin DichgansInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian-University (LMU), Munich, Germany Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Fergus DoubalDepartment of Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
Marco DueringInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian-University (LMU), Munich, Germany.
Carole DufouilInserm UMR897, University of Bordeaux, Bordeaux, France
Emrah DuzelDepartment of Cognitive Neurology and Dementia Research, University of Magdeburg, Magdeburg, Germany.
Franz FazekasDepartment of Neurology, Medical University of Graz, Graz, Austria.
Vladimir HachinskiDepartment of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
M Arfan IkramDepartment of Radiology and Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Jennifer LinnDepartment of Neuroradiology, University Hospital Munich, Munich, Germany.
Paul M MatthewsDepartment of Medicine, Division of Brain Sciences, Imperial College London, London, UK.
Bernard MazoyerCNRS-CEA UMR5296, University of Bordeaux, Bordeaux, France.
Vincent MokDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Bo NorrvingDepartment of Clinical Sciences, Neurology, Lund University, Lund, Sweden.
John T O'BrienDepartment of Psychiatry, University of Cambridge, Cambridge, UK.
Leonardo PantoniNeurofarba Department, University of Florence, Florence, Italy.
Stefan RopeleDepartment of Neurology, Medical University of Graz, Graz, Austria.
Perminder SachdevCentre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia.
Reinhold SchmidtDepartment of Neurology, Medical University of Graz, Graz, Austria.
Sudha SeshadriDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Eric E SmithDepartment of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
Luciano A SposatoDepartment of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
Blossom StephanInstitute of Health and Society, Newcastle University Institute of Ageing, Newcastle University, Newcastle, UK.
Richard H SwartzDepartment of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Christophe TzourioInserm UMR897, University of Bordeaux, Bordeaux, France
Mark van BuchemDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Aad van der LugtDepartment of Radiology and Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Robert van OostenbruggeDepartment of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands.
Meike W VernooijDepartment of Radiology and Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Anand ViswanathanDepartment of Neurology, J. Philip Kistler Stroke Research Center, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
David WerringDepartment of Brain Repair and Rehabilitation, Stroke Research Group, UCL, London, UK.
Frank WollenweberInstitute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian-University (LMU), Munich, Germany.
Joanna M WardlawDepartment of Neuroimaging Sciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK  Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), University of Edinburgh, Edinburgh, UK.
Hugues ChabriatUniversity Paris Diderot, Sorbonne Paris Cité, UMRS 1161 INSERM, Paris, France DHU NeuroVasc, Sorbonne Paris Cité, Paris, France Department of Neurology, AP-HP, Lariboisière Hospital, Paris, France hugues.chabriat@aphp.fr.

Funding

UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Medical Research Council G9409634Medical Research Council MR/J006971/1Medical Research Council MR/M024903/1NIA NIH HHS P30 AG010129NINDS NIH HHS R01 NS017950
6 · The paper itself

Abstract

Brain imaging is essential for the diagnosis and characterization of cerebral small vessel disease. Several magnetic resonance imaging markers have therefore emerged, providing new information on the diagnosis, progression, and mechanisms of small vessel disease. Yet, the reproducibility of these small vessel disease markers has received little attention despite being widely used in cross-sectional and longitudinal studies. This review focuses on the main small vessel disease-related markers on magnetic resonance imaging including: white matter hyperintensities, lacunes, dilated perivascular spaces, microbleeds, and brain volume. The aim is to summarize, for each marker, what is currently known about: (1) its reproducibility in studies with a scan-rescan procedure either in single or multicenter settings; (2) the acquisition-related sources of variability; and, (3) the techniques used to minimize this variability. Based on the results, we discuss technical and other challenges that need to be overcome in order for these markers to be reliably used as outcome measures in future clinical trials. We also highlight the key points that need to be considered when designing multicenter magnetic resonance imaging studies of small vessel disease.

Indexed as

BiomarkersBrainCerebral Small Vessel DiseasesHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMicrovesselsReproducibility of ResultsBiomarkersatrophybrain volumecerebral small vessel diseaselacunesMagnetic resonance imagingmarkermicrobleedsperivascular spacesrepeatabilityreproducibilityvariabilitywhite matter hyperintensities

Identifiers

PMID27170700
PMCPMC4976752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.